Thomas J Calvert, MD
Urology · Lakewood
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 13 years
- Graduated 2013
Offices
1 location · Greater Long Beach Genito-Urinary Med Grp · 4 clinicians in this group
Hospitals listed: Greater El Monte Community Hospital · St Mary Medical Center · Uci Health-Lakewood · Uci Health-Orange. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Calvert’s office at (562) 630-0423 to ask if they take your plan before you enroll.
California Medical Board record
Licence A162971 · Current
Licensed to practise in California · since 2019 · expires 2027-06-30 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Urology - Urology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Greater El Monte Community HospitalSouth El Monte, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency departmentPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- St Mary Medical CenterLong Beach, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 62% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.287, Oct 2024 – Sep 2025
- Uci Health-LakewoodLakewood, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 1 of 5 · 48% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.105, Oct 2024 – Sep 2025
- Uci Health-OrangeOrange, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Chao Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.44 (3.82 to 7.06) · 2,934 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 82.98 (46.2 to 119.76) · 170 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.422, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.56, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.547, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.356, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.449, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 1,287 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Greater El Monte Community Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 109 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.49 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 29 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 170 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.8 · 392 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,005 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,022 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.96 (1.33 to 6.58) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.32 (0.59 to 4.05) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.46) · 857 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.419 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.866 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.025 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 62 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.7 · 179 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.1 · 219 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 44 cases | None | Jul 2023 – Jun 2025 |
What patients said (188 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 59% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for St Mary Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 2 better, 3 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.287 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2) · 447 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1 (0.6 to 1.39) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 157.28 (101.7 to 212.85) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.7 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 104 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.5 · 163 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,282 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 2,406 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,539 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.24 (1.82 to 6.66) · 360 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.79) · 354 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.37 (0 to 17.99) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.06 (0.79 to 9.33) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.69 (0 to 1.46) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 34 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.676 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.303 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.421 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 159 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.2 · 269 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 29.9 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -47.9 · 111 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 10.1 · 139 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 257 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 124 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 44 cases | No different | Jan 2024 – Dec 2024 |
What patients said (464 patients answered, 9% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Uci Health-Lakewood
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.105 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 512 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.77 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.76 (139.14 to 246.38) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 264 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.5 · 223 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,866 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.51) · 3,098 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,262 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.33 to 6.11) · 498 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.91 (1.29 to 4.53) · 492 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.25 (1.53 to 20.97) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.91 (0.24 to 1.58) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.584 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.498 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.265 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 181 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 403 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.3 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 89.6 · 289 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.5) · 95 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 80 cases | No different | Jan 2024 – Dec 2024 |
What patients said (391 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 78% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 49% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 60% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 48% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 80% |
See every measure and the patient survey for Uci Health-Orange
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.44 (3.82 to 7.06) · 2,934 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 82.98 (46.2 to 119.76) · 170 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.422 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.56 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.547 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.356 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 1,287 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.25 to 1.87) · 2,297 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.67 to 1.13) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 59 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 104 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 331 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 416 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 330 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,269 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.33) · 8,263 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.37) · 8,703 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.95 (0.57 to 3.32) · 1,647 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (1.33 to 3.71) · 2,756 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.15 (2.82 to 11.48) · 1,643 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.78 (2.24 to 7.33) · 1,680 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.98 (0.61 to 3.36) · 871 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.28 (0 to 0.77) · 7,232 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 170 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.546 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 165 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 556 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 75.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0 · 391 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.4 · 436 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 556 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.6) · 846 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.8 (10 to 14) · 846 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.9 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 110 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.6 to 13.8) · 2,457 cases | No different | Jan 2022 – Dec 2024 |
What patients said (575 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$84,852
Medicare paid this office $84,852 for 287 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 125 | $17,273 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 143 | $17,252 | $107 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $6,120 | $211 |
| New patient visit (45+ min) | 50 | $6,120 | $122 |
| Return visit (30+ min) | 35 | $4,203 | $98 |
See all 11 services
| Short return visit (20+ min) | 125 | $17,273 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 143 | $17,252 | $107 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $6,120 | $211 |
| New patient visit (45+ min) | 50 | $6,120 | $122 |
| Return visit (30+ min) | 35 | $4,203 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,045 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,424 | $143 |
| New patient visit (30+ min) | 16 | $1,018 | $64 |
| Injection of drug or substance under skin or into muscle | 46 | $1,016 | $12 |
| Complicated insertion of bladder tube | 12 | $746 | $62 |
| Injection, ceftriaxone sodium, per 250 mg | 41 | $46 | None |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of bladder and urethra using an endoscope | – | 31 | 56 | 19 | 24 | 29 |
| Ultrasound measurement of bladder capacity after voiding | 35 | 67 | – | – | – | – |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | – | 15 | 22 | – | – | – |
| Crushing of stone of ureter with insertion of stent using an endoscope | – | 16 | 19 | – | – | – |
| Insertion of stent in ureter using an endoscope | – | 12 | 20 | – | – | – |
| Complicated insertion of bladder tube | – | – | – | – | 16 | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
287 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 14% · Women 30% · Also on Medicaid 80% · Health risk score 2.86. Sicker patients than 9 in 10 peers; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 62% · Chronic kidney disease 52% · Depression 43% · Coronary heart disease 42% · Heart failure 41% · COPD 40% · Dementia 37% · Atrial fibrillation 32% · Stroke 29% · Cancer 20%.
The office billed $234,468, Medicare allowed $112,189 and paid $84,852; for 1,005 services of 46 kinds; $78 of it was for drugs given in the office and $84,774 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 287 | 1,005 | 74 | 2.86 | $234,468 | $84,852 |
| 2023 | 254 | 952 | 72 | 2.74 | $232,187 | $89,590 |
| 2022 | 97 | 299 | 72 | 2.46 | $84,432 | $30,396 |
| 2021 | 367 | 1,259 | 73 | 1.46 | $399,268 | $138,350 |
| 2020 | 227 | 796 | 73 | 1.53 | $210,473 | $68,181 |
| 2019 | 47 | 127 | 72 | 1.49 | $29,140 | $9,446 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 138 | $17,903 | $111 |
| Short return visit (20+ min) | 91 | $12,830 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $12,161 | $66 |
| New patient visit (45+ min) | 56 | $6,407 | $114 |
| Return visit (30+ min) | 43 | $5,491 | $108 |
| Diagnostic exam of bladder and urethra using an endoscope | 24 | $5,174 | $216 |
| Complicated insertion of bladder tube | 14 | $1,002 | $63 |
| Injection of drug or substance under skin or into muscle | 31 | $536 | $13 |
| Injection, ceftriaxone sodium, per 250 mg | 31 | $31 | None |
2022: 7 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,938 | $115 |
| New patient visit (45+ min) | 37 | $4,801 | $130 |
| Diagnostic exam of bladder and urethra using an endoscope | 19 | $4,274 | $225 |
| Short return visit (20+ min) | 27 | $4,075 | $80 |
| Return visit (30+ min) | 11 | $1,359 | $105 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,277 | $33 |
| Injection, ceftriaxone sodium, per 250 mg | 21 | $11 | None |
2021: 15 services
| Short return visit (20+ min) | 284 | $41,297 | $72 |
| New patient visit (45+ min) | 220 | $28,504 | $130 |
| Diagnostic exam of bladder and urethra using an endoscope | 51 | $11,370 | $203 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $9,781 | $611 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $6,602 | $347 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 21 | $5,718 | $260 |
| Biopsy of prostate gland | 20 | $3,989 | $199 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $2,876 | $103 |
| Ultrasound scan of pelvic region through rectum | 20 | $2,434 | $122 |
| Insertion of stent in ureter using an endoscope | 17 | $1,809 | $90 |
| Simple insertion of temporary bladder tube | 12 | $1,160 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,075 | $60 |
| Return visit (30+ min) | 11 | $1,039 | $94 |
| Injection of drug or substance under skin or into muscle | 15 | $178 | $12 |
| Injection, ceftriaxone sodium, per 250 mg | 15 | $28 | None |
2020: 13 services
| New patient visit (45+ min) | 122 | $15,744 | $129 |
| Short return visit (20+ min) | 154 | $15,686 | $59 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $4,976 | $311 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $4,887 | $158 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 15 | $3,448 | $230 |
| Insertion of stent in ureter using an endoscope | 11 | $1,498 | $125 |
| New patient visit (30+ min) | 23 | $878 | $38 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $802 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $785 | $60 |
| Ultrasound measurement of bladder capacity after voiding | 63 | $507 | $8 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $258 | $17 |
| Injection of drug or substance under skin or into muscle | 11 | $131 | $11 |
| Automated urinalysis test | 20 | $47 | $2 |
2019: 4 services
| New patient visit (60+ min) | 12 | $2,020 | $168 |
| New patient visit (30+ min) | 22 | $1,885 | $86 |
| Short return visit (20+ min) | 18 | $1,160 | $61 |
| Ultrasound measurement of bladder capacity after voiding | 30 | $356 | $10 |
Medicaid work
$61,101 in 2024
Medicaid paid $61,101 for 2,488 billed services this clinician did in 2024, up to 121 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 1,051 | $19,047 |
| New patient visit (45+ min) | 412 | $16,171 |
| New patient visit (30+ min) | 263 | $11,270 |
| CYSTOURETHROSCOPY | 91 | $5,164 |
| Return visit (30+ min) | 160 | $3,772 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 93 | $2,828 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 241 | $2,722 |
| Injection, ceftriaxone sodium, per 250 mg | 177 | $128 |
| 2024 | 2,488 | 8 | 121 | $61,101 |
| 2023 | 1,513 | 9 | 69 | $56,876 |
| 2022 | 44 | 2 | 14 | $1,947 |
| 2021 | 290 | 2 | 21 | $15,780 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 215 | $12,830 |
| Short return visit (20+ min) | 475 | $11,745 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 208 | $11,265 |
| New patient visit (30+ min) | 206 | $10,197 |
| Return visit (30+ min) | 121 | $3,667 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 112 | $3,392 |
| CYSTOURETHROSCOPY | 42 | $2,639 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 83 | $889 |
| Injection, ceftriaxone sodium, per 250 mg | 51 | $253 |
2022
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 15 | $1,231 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 29 | $715 |
2021
| New patient visit (45+ min) | 133 | $10,525 |
| Short return visit (20+ min) | 157 | $5,255 |
Drugs they prescribed that Part D paid
$37,274
Pharmacies billed $37,274 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 509) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
494 generic and 15 brand-name prescriptions · $37,274 in drug cost · 122 antibiotic prescriptions to 89 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tamsulosin | 204 | $2,736 | $13 |
| Solifenacin | 35 | $2,636 | $75 |
| Finasteride | 55 | $898 | $16 |
| Amoxicillin-Clavulanate Potass | 31 | $216 | $7 |
| Oxybutynin Chloride | 13 | $159 | $12 |
See all 9 drugs
| Tamsulosin | 204 | $2,736 | $13 |
| Solifenacin | 35 | $2,636 | $75 |
| Finasteride | 55 | $898 | $16 |
| Amoxicillin-Clavulanate Potass | 31 | $216 | $7 |
| Oxybutynin Chloride | 13 | $159 | $12 |
| Ciprofloxacin | 48 | $92 | $2 |
| Sulfamethoxazole-Trimethoprim | 26 | $59 | $2 |
| Terazosin | 12 | $57 | $5 |
| Sildenafil Citrate | 20 | $28 | $1 |
Year by year
| 2024 | 509 | 199 | 0% (0) | 3% | $37,274 |
| 2023 | 271 | 118 | 0% (0) | 4% | $48,763 |
| 2022 | 180 | 78 | None | None | $10,047 |
| 2021 | 636 | 190 | 5% (34) | None | $16,583 |
| 2020 | 343 | 101 | 4% (13) | None | $12,496 |
| 2019 | 70 | 36 | 20% (14) | None | $2,462 |
| 2018 | 49 | 35 | 53% (26) | 0% | $214 |
| 2017 | 25 | 17 | 56% (14) | None | $479 |
| 2016 | 101 | 61 | 41% (41) | 0% | $745 |
| 2015 | 86 | 56 | 47% (40) | None | $657 |
| 2014 | 58 | 26 | 31% (18) | None | $3,221 |
| 2013 | 31 | 21 | 55% (17) | None | $510 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Tamsulosin | 102 | $1,601 | $16 |
| Amoxicillin-Clavulanate Pot Er | 11 | $787 | $72 |
| Oxybutynin Chloride | 19 | $757 | $40 |
| Finasteride | 22 | $600 | $27 |
| Sildenafil Citrate | 19 | $166 | $9 |
| Sulfamethoxazole-Trimethoprim | 18 | $107 | $6 |
| Ciprofloxacin | 29 | $95 | $3 |
2022: 3 drugs
| Tamsulosin | 88 | $1,464 | $17 |
| Finasteride | 45 | $936 | $21 |
| Terazosin | 12 | $190 | $16 |
2021: 11 drugs
| Finasteride | 143 | $3,198 | $22 |
| Tamsulosin | 183 | $2,820 | $15 |
| Nitrofurantoin Mono-Macro | 40 | $807 | $20 |
| Oxybutynin Chloride | 14 | $340 | $24 |
| Cephalexin | 30 | $280 | $9 |
| Terazosin | 12 | $205 | $17 |
| Sulfamethoxazole-Trimethoprim | 45 | $201 | $4 |
| Tramadol | 33 | $93 | $3 |
| Ciprofloxacin | 32 | $86 | $3 |
| Levofloxacin | 12 | $79 | $7 |
| Amoxicillin | 16 | $78 | $5 |
2020: 8 drugs
| Finasteride | 64 | $1,268 | $20 |
| Tamsulosin | 100 | $1,146 | $11 |
| Nitrofurantoin Mono-Macro | 17 | $627 | $37 |
| Oxybutynin Chloride | 16 | $266 | $17 |
| Cephalexin | 29 | $202 | $7 |
| Sulfamethoxazole-Trimethoprim | 23 | $202 | $9 |
| Terazosin | 12 | $108 | $9 |
| Tramadol | 13 | $29 | $2 |
2019: 2 drugs
| Tamsulosin | 14 | $180 | $13 |
| Tramadol | 11 | $24 | $2 |
2018: 1 drug
| Tramadol | 21 | $51 | $2 |
2016: 2 drugs
| Oxycodone | 25 | $132 | $5 |
| Levofloxacin | 17 | $74 | $4 |
2015: 2 drugs
| Oxycodone | 19 | $135 | $7 |
| Ciprofloxacin | 18 | $52 | $3 |
2014: 1 drug
| Oxycodone | 12 | $171 | $14 |
Money from drug and device companies
$1,140 in 2025
| 2025 | 11 | 28 | None | $1,140 |
| 2024 | 11 | 16 | None | $529 |
| 2023 | 8 | 11 | None | $341 |
| 2022 | 11 | 22 | None | $821 |
| 2021 | 6 | 13 | None | $224 |
| 2020 | 7 | 10 | None | $164 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Calyxo | Cvac Aspiration System | $306 | 3 payments
|
| Coloplast | Altis | $272 | 7 payments
|
| Boston Scientific | Rezum Generator | $163 | 4 payments
|
| Pfizer | Xtandi | $137 | 7 payments
|
| Medtronic | Interstim | $90 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $41 | 1 payment
|
See all 28 published payments
| Pfizer | Meals · 2025-12-24 | Xtandi | $29 |
| Boston Scientific | Meals · 2025-12-18 | Solyx Blue | $22 |
| Pfizer | Meals · 2025-12-04 | Xtandi | $29 |
| Medtronic | Meals · 2025-12-01 | Interstim | $90 |
| Boston Scientific | Meals · 2025-10-28 | Bulkamid | $45 |
| Abbvie | Meals · 2025-10-01 | Botox | $34 |
| Coloplast | Meals · 2025-09-25 | Altis | $15 |
| Calyxo | Meals · 2025-09-19 | Cvac Aspiration System | $30 |
| Steris | Meals · 2025-09-17 | Uretero1 | $25 |
| Coloplast | Meals · 2025-09-10 | Altis | $163 |
| Calyxo | Meals · 2025-09-10 | Cvac Aspiration System | $133 |
| Pfizer | Meals · 2025-09-04 | Xtandi | $21 |
| Immunitybio | Meals · 2025-08-04 | Anktiva | $30 |
| Pfizer | Meals · 2025-07-24 | Xtandi | $6 |
| Boston Scientific | Meals · 2025-07-11 | Rezum Generator | $43 |
| Pfizer | Meals · 2025-06-11 | Xtandi | $27 |
| Pfizer | Meals · 2025-06-11 | Xtandi | $3 |
| Coloplast | Meals · 2025-05-15 | Altis | $37 |
| Coloplast | Meals · 2025-05-15 | Altis | $20 |
| Coloplast | Meals · 2025-05-15 | Altis | $28 |
| Pfizer | Meals · 2025-05-15 | Xtandi | $23 |
| Boston Scientific | Meals · 2025-05-14 | Rezum Generator | $53 |
| Coloplast | Meals · 2025-04-30 | Altis | $2 |
| Coloplast | Meals · 2025-04-30 | Altis | $8 |
| Dendreon Pharmaceuticals | Meals · 2025-04-14 | Provenge | $41 |
| Calyxo | Meals · 2025-02-26 | Cvac Aspiration System | $143 |
| Laborie Medical Technologies | Meals · 2025-01-30 | Optilume Bph Drug Coated Balloon Catheter | $26 |
| Astellas Pharma US | Meals · 2025-01-15 | Xtandi | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $529
| PROCEPT BioRobotics | Aquabeam System | $139 | 1 payment
|
| Bluewind Medical | Revi | $109 | 1 payment
|
| Teleflex | Solesta | $78 | 4 payments
|
| Ethicon US | Stratafix | $42 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $40 | 2 payments
|
| Stryker | Fluid Management System | $31 | 1 payment
|
| Coloplast | Altis | $20 | 1 payment
|
| Pfizer | Xtandi | $20 | 1 payment
|
| Abbott Laboratories | Eterna | $19 | 1 payment
|
| Boston Scientific | Solyx Sis System | $16 | 1 payment
|
| Innovation Technologies | Irrisept | $15 | 1 payment
|
2023: $341
| Teleflex | Urolift | $77 | 2 payments
|
| Axonics | Bulkamid | $64 | 1 payment
|
| AbbVie | Botox | $61 | 2 payments
|
| Pfizer | Xtandi | $43 | 2 payments
|
| Stryker | Fluid Management System | $30 | 1 payment
|
| Cook Medical | Resonance | $25 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $23 | 1 payment
|
| Boston Scientific | Rezum Generator | $19 | 1 payment
|
2022: $821
| Teleflex | Urolift | $302 | 3 payments
|
| Medtronic | Interstim | $134 | 7 payments
|
| Astellas Pharma US | None | $100 | 1 payment
|
| Coloplast | Altis | $77 | 2 payments
|
| Myriad Genetic Laboratories | Prolaris | $44 | 2 payments
|
| Abbvie | Botox | $42 | 2 payments
|
| Boston Scientific | Rezum Generator | $27 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $25 | 1 payment
|
| Endo Pharmaceuticals | Xiaflex | $24 | 1 payment
|
| Urovant Sciences | Gemtesa | $24 | 1 payment
|
| UroGen Pharma | Jelmyto | $23 | 1 payment
|
2021: $224
| Endo Pharmaceuticals | Xiaflex | $53 | 3 payments
|
| Coloplast | Speedicath | $53 | 3 payments
|
| Urogen Pharma | Jelmyto | $44 | 2 payments
|
| Astellas Pharma US | Myrbetriq | $43 | 3 payments
|
| Sagent Pharmaceuticals | Glydo | $18 | 1 payment
|
| Axonics | Axonics R-Snm System | $13 | 1 payment
|
2020: $164
| Coloplast | Continence Care | $75 | 4 payments
|
| Sagent Pharmaceuticals | Glydo | $20 | 1 payment
|
| Endo Pharmaceuticals | Edex | $16 | 1 payment
|
| Axonics Modulation Technologies | Axonics R-Snm System | $14 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $13 | 1 payment
|
| Urogen Pharma | Jelmyto | $13 | 1 payment
|
| Dentsply Ih | Cerec | $12 | 1 payment
|
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
| Asked about alcoholPatients screened for unhealthy alcohol use, with counseling if needed | 100%That's most of the people this applied to. | 462 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 331 |
| Medications listed in the chartVisits where the current medication list was documented | 15%That's few of the people this applied to. | 1,618 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 306 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 320 |
| Tobacco Use and Help with Quitting Among AdolescentsAs Medicare defines this measure | 98% | 42 |
| Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and OlderAs Medicare defines this measure | 97% | 97 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 96%That's most of the people this applied to. | 915 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Care transition standard operational improvements
- Checks the state prescription-drug database before prescribing
- Collects patient feedback
- Completion of the AMA STEPS Forward program
- Diabetes screening
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Provides care coordination
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Exempt from immunization registry reporting
Professional record
- NPI
- 1982042677
- Licence
- CA A162971, MA 256526California A162971: Current · expires 2027-06-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Surgery (208600000X)
- Mailing address
- 3650 South St Ste 408, Lakewood, CA, 90712
- NPI first listed
- 2013-06-05
- NPI last updated
- 2022-06-13
- NPI record certified
- 2022-06-13
This is when the NPI record was last certified, not a medical board exam.